CreativeOne Wealth LLC grew its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 64.6% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 6,644 shares of the company's stock after acquiring an additional 2,608 shares during the quarter. CreativeOne Wealth LLC's holdings in Cardinal Health were worth $915,000 as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of the business. Principal Financial Group Inc. increased its stake in Cardinal Health by 5.3% during the 1st quarter. Principal Financial Group Inc. now owns 315,817 shares of the company's stock worth $43,510,000 after acquiring an additional 15,956 shares during the period. Kingswood Wealth Advisors LLC increased its stake in Cardinal Health by 17.2% during the 1st quarter. Kingswood Wealth Advisors LLC now owns 3,119 shares of the company's stock worth $429,000 after acquiring an additional 457 shares during the period. Assenagon Asset Management S.A. increased its stake in Cardinal Health by 25.8% during the 1st quarter. Assenagon Asset Management S.A. now owns 13,147 shares of the company's stock worth $1,811,000 after acquiring an additional 2,694 shares during the period. Golden State Wealth Management LLC increased its stake in Cardinal Health by 569.5% during the 1st quarter. Golden State Wealth Management LLC now owns 395 shares of the company's stock worth $54,000 after acquiring an additional 336 shares during the period. Finally, North Capital Inc. bought a new position in Cardinal Health during the 1st quarter worth $83,000. Institutional investors own 87.17% of the company's stock.
Wall Street Analyst Weigh In
CAH has been the topic of a number of analyst reports. UBS Group reiterated a "buy" rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Citigroup reiterated a "neutral" rating and set a $170.00 price objective (up from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Evercore ISI reduced their price objective on shares of Cardinal Health from $200.00 to $190.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 13th. Argus set a $189.00 price objective on shares of Cardinal Health in a research note on Friday, August 22nd. Finally, Jefferies Financial Group set a $150.00 target price on Cardinal Health in a report on Tuesday, August 12th. Twelve equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, Cardinal Health has an average rating of "Moderate Buy" and a consensus price target of $165.93.
View Our Latest Stock Analysis on CAH
Insider Buying and Selling at Cardinal Health
In related news, insider Jessica L. Mayer sold 38,078 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the sale, the insider directly owned 48,457 shares in the company, valued at $7,211,370.74. This trade represents a 44.00% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Ola M. Snow sold 28,151 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the sale, the insider owned 15,431 shares in the company, valued at approximately $2,298,293.14. This represents a 64.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 271,676 shares of company stock worth $40,489,525 over the last quarter. Insiders own 0.09% of the company's stock.
Cardinal Health Price Performance
Shares of NYSE CAH traded down $1.78 during mid-day trading on Thursday, hitting $148.78. 1,121,415 shares of the stock traded hands, compared to its average volume of 2,413,372. Cardinal Health, Inc. has a twelve month low of $106.54 and a twelve month high of $168.44. The company has a market cap of $35.53 billion, a PE ratio of 23.07, a price-to-earnings-growth ratio of 1.26 and a beta of 0.73. The firm has a 50 day simple moving average of $156.54 and a two-hundred day simple moving average of $146.51.
Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. During the same quarter last year, the business posted $1.84 EPS. Cardinal Health's revenue for the quarter was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 annualized dividend and a yield of 1.4%. Cardinal Health's dividend payout ratio (DPR) is currently 31.63%.
About Cardinal Health
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Further Reading

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report